Copyright
©The Author(s) 2018.
World J Gastroenterol. Aug 28, 2018; 24(32): 3626-3636
Published online Aug 28, 2018. doi: 10.3748/wjg.v24.i32.3626
Published online Aug 28, 2018. doi: 10.3748/wjg.v24.i32.3626
Table 3 Prospective studies of downstaging of hepatocellular carcinoma before liver transplantation
Ref. | Criteria | Downstagingsuccess rate (%) | LT rate(%) | Survival,time and rate (%) | HCC recurrence (%) |
Roayaie et al[11], 2002 | Mount Sinai protocol | 53.75 | 5 yr OS (44) 5 yr DFS (48) 5 yr DFS, tumors < 7 cm (55) | ||
Yao et al[72], 2015 | Beyond Milan: single tumor ≤ 8 cm, 2–3 tumors (at least one > 3 and ≤ 5 cm, total diameter ≤ 8 cm), 4–5 tumors each ≤ 3 cm and total diameter ≤ 8 cm | To MC: 65.3 | 54.2 | 5 yr OS (77.8) 5 yr I-to-T (56.1) | 7.8 |
Bologna criteria - Ravaioli et al[35], 2008 | Beyond Milan: 1 lesion ≤ 6 cm, 2 lesions ≤ 5 cm, 3–5 lesions ≤ 4 cm and total diameter ≤ 12 cm | To MC: 72.9 | 66.7 | 3 yr DFS (71) 3 yr I-to-T (56.3) | 18.8 |
Millonig et al[73], 2007 | UCSF | RECIST | 84.8 | 5 yr CR (66.6); PR (63.7); NR (25) | 25 |
Graziadei et al[37], 2003 | Beyond Milan, no upper limit | Partial response (> 50% of tumor size) | 66.6 | 4 yr OS (41); 5 yr I-to-T (31) | 30 |
- Citation: Pavel MC, Fuster J. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. World J Gastroenterol 2018; 24(32): 3626-3636
- URL: https://www.wjgnet.com/1007-9327/full/v24/i32/3626.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i32.3626